NCT04250480 is a NA clinical trial of beta-alanine in Cognitive Impairment, sponsored by University of Central Florida.

Who is sponsoring NCT04250480?

NCT04250480 is sponsored by University of Central Florida.

What drugs are being tested in NCT04250480?

Interventions in NCT04250480: beta-alanine, placebo.

What condition does NCT04250480 study?

NCT04250480 studies Cognitive Impairment.

Is NCT04250480 still recruiting?

NCT04250480 is currently completed. Last updated 31 January 2020.

Last reviewed 2020-01-31 · How we verify

NCT04250480

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Changes in Cognition During a 24-h Simulated Military Operation

Completed NA Last updated 31 January 2020

What this trial tests

NA trial testing beta-alanine in Cognitive Impairment in 40 participants. Completed in 15 April 2018.

Timeline

2 October 2017

Primary endpoint
15 April 2018

15 April 2018

Quick facts

Lead sponsor	University of Central Florida
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	40
Start date	2 October 2017
Primary completion	15 April 2018
Estimated completion	15 April 2018
Sites	1 location across United States

Drugs / interventions tested

beta-alanine — full drug profile →
placebo

Conditions studied

Cognitive Impairment — all drugs for Cognitive Impairment →

Sponsor

University of Central Florida

Who can join

Adults 18 to 35, male only, with Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sustained military operations (SUSOPs) result in psychological stress and cognitive dysfunction, which may be related to the recruitment of classical monocytes into the brain. Goals: * To investigate the effect of sustained-release beta-alanine on changes in cognition and markers of immune cell recruitment during a 24-hour simulated military operation. * To examine associations between changes cognition and changes in markers mediating immune cell recruitment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of beta-alanine

Trials testing the same drug.

NCT03803800 — Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis · NA · completed

Other recruiting trials for Cognitive Impairment

Currently open trials in the same condition.

NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
NCT07396779 — Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog · NA · active not recruiting
NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i · Phase 3 · recruiting
NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting

Other University of Central Florida trials

Trials by the same sponsor.

NCT07203430 — Biopsychosocial Factors and Muscle Morphology After a Resistance Exercise · NA · completed
NCT07214883 — UCF MammoChat: Image Repository · recruiting
NCT06999057 — Quadriceps Motor Unit Adaptation to Simulated Knee Injury · NA · not yet recruiting
NCT06979713 — Yoga, Education, and Nidra (YEN) for Chronic Low Back Pain: A Pilot Study on Pain Modulation, Well-Being, and Sleep · NA · not yet recruiting
NCT06512168 — Measuring Aided Language Development · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04250480 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Central Florida
Last refreshed: 31 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04250480.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing